Physitrack PLC — Transactions under Share Buy-back Programme

PTRKRegulatory press release31.08.2026, 08.30

Physitrack PLC (Nasdaq First North Growth Market Stockholm: PTRK) (“Physitrack” or the “Company”) announced on 21 July 2026 a share buy-back programme, which commenced on 10 August 2026. The Company reports below the transactions undertaken under the programme during the week of 24 August 2026 to 28 August 2026 (inclusive), in accordance with Article 5 of the Market Abuse Regulation (EU) 596/2014 (“MAR”) and Commission Delegated Regulation (EU) 2016/1052.

Summary of transactions

Period	24 August 2026 – 28 August 2026
Total shares repurchased during the week	6,673
Volume-weighted average price paid (SEK)	8.0964
Total consideration paid (SEK)	54,027.06
Total shares held by the Company (treasury) following these transactions	21,173
Total outstanding shares in the Company	16,260,766
Treasury holding as % of issued share capital	0.13%

Individual transactions

Date	Quantity	Average price (SEK)
2026-08-24	1,000	8.08
2026-08-25	2,000	8.16
2026-08-26	1,500	8.16
2026-08-27	1,500	8.0133
2026-08-28	673	7.9749

The buy-back programme is conducted within the safe harbour provided by Article 5 of MAR and Commission Delegated Regulation (EU) 2016/1052. The purpose of the programme is to enable the Company to meet its obligations under its employee share plans. The programme is executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details

1. Issuer	Physitrack PLC, LEI 213800PC4QYNWHPCP774
2. Instrument/ISIN	Ordinary shares / GB00BYX22590
3. Trading venue	Nasdaq First North Growth Market Stockholm (PTRK)
4. Currency	SEK
5. Purpose of buy-back	To meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR)
6. Executing broker	Pareto Securities (non-discretionary mandate)

This disclosure is made in accordance with Physitrack PLC's obligations under Article 5 of MAR and Commission Delegated Regulation (EU) 2016/1052.

About Physitrack

Physitrack plc (Nasdaq First North: PTRK), d/b/a Physitrack Group, is a global digital health and wellness SaaS delivering personalized, scalable remote care through its Physitrack and Champion Health platforms.
Physitrack enables healthcare providers to deliver and manage app-guided physical and occupational rehabilitation with measurable patient outcomes and built-in billing and reimbursement support, while Champion Health provides businesses with mental, physical, and financial wellbeing solutions to support workforce health and productivity.

Physitrack Group’s solutions seamlessly integrate with existing systems, including EMR/EHR/PMS connectivity, and are trusted by more than 80,000 providers and organizations across 180+ countries. For more information, visit www.physitrackgroup.com and follow us on LinkedIn and X.